P2RY12 and myocardial infarction: As we mentioned in the discussion, this study excluded patients who took P2Y12 inhibitors such as clopidogrel and ticagrelor, which were administered before and after percutaneous coronary intervention; therefore, it is highly likely that many patients with acute myocardial infarction who were treated with percutaneous coronary intervention were excluded from the study.